MetaCap

Obsidian Therapeutics Inc. Company Profile

NASDAQ: OBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.00-0.15 (-1.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Obsidian Therapeutics at a glance

Obsidian Therapeutics Inc. (NASDAQ: OBX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Cambridge, MA. Obsidian Therapeutics is led by Dr. Madan Jagasia M.D., M.S. and employs about 87 people. At a market capitalization of $750.6 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0002130606, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Obsidian Therapeutics do?

Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluated in clinical trials for advanced solid tumors, advanced melanoma, and relapsed refractory non-small cell lung cancer. It utilizes a proprietary Cytodriver technology platform designed to regulate protein function using FDA-approved small-molecule drugs and is advancing tumor-infiltrating lymphocyte (TIL) cell therapies that leverage mbIL15 to enhance persistence, antitumor activity, and clinical safety. Access to investigational therapies is currently limited to participation in clinical trials, and the company collaborates with other organizations to apply its platform technology. The company was founded in 2015 and is based in Cambridge, Massachusetts.

Business description based on the company's public filings.

Company information

Legal name
Obsidian Therapeutics Inc.
Ticker
NASDAQ: OBX
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Madan Jagasia M.D., M.S.
Employees
87
Headquarters
1030 Massachusetts Avenue, Cambridge, MA, United States
Phone
781 806 6245
Market cap
$750.55M
SEC CIK
0002130606

Companies similar to Obsidian Therapeutics

OBX peer companies
CompanyPrice% ChgMarket capCompare
IVAInventiva S.A. American Depository Shares3.14-8.99%$750.78Mvs OBX
ARDXArdelyx Inc.2.99-2.29%$751.60Mvs OBX
RIGLRigel Pharmaceuticals Inc.40.09-2.67%$754.89Mvs OBX
ORICOric Pharmaceuticals Inc.7.36-4.42%$764.94Mvs OBX
COLLCollegium Pharmaceutical Inc.24.72-1.94%$768.18Mvs OBX
IRWDIronwood Pharmaceuticals Inc. Class A4.70-0.21%$778.09Mvs OBX
SNDXSyndax Pharmaceuticals Inc.8.72-4.49%$785.05Mvs OBX
VSTMVerastem Inc.6.33-7.73%$797.67Mvs OBX

Related